Promise of periodontal ligament stem cells in regeneration of periodontium

Abstract

A great number of patients around the world experience tooth loss that is attributed to irretrievable damage of the periodontium caused by deep caries, severe periodontal diseases or irreversible trauma. The periodontium is a complex tissue composed mainly of two soft tissues and two hard tissues; the former includes the periodontal ligament (PDL) tissue and gingival tissue, and the latter includes alveolar bone and cementum covering the tooth root. Tissue engineering techniques are therefore required for regeneration of these tissues. In particular, PDL is a dynamic connective tissue that is subjected to continual adaptation to maintain tissue size and width, as well as structural integrity, including ligament fibers and bone modeling. PDL tissue is central in the periodontium to retain the tooth in the bone socket, and is currently recognized to include somatic mesenchymal stem cells that could reconstruct the periodontium. However, successful treatment using these stem cells to regenerate the periodontium efficiently has not yet been developed. In the present article, we discuss the contemporary standpoints and approaches for these stem cells in the field of regenerative medicine in dentistry.

Periodontal ligament stem cells (PDLSCs) represent a promising cell-based therapy in reconstructive dentistry for the treatment of damaged periodontium. Researchers have therefore attempted to identify PDLSCs and disclose their characteristics. In the 1980s, the cells that exhibited small size, a high nuclear/cytoplasmic ratio and slow cell division were reported to be localized in regions adjacent to blood vessels, and these cells were suggested as PDLSCs [1, 2]. In 2004, human PDLSCs exhibiting self-renewal and multipotent capacities were first isolated from human periodontal ligament (PDL) tissue [3].

PDLSCs exhibit unique properties. This group of authors and others have demonstrated the plasticity of PDLSCs to differentiate into osteoblastic and adipocytic cells [4, 5]. Further more, Seo and colleagues identified STRO-1 and CD146 as potent surface markers of PDLSCs [3]. The percentage of cells resident in PDL tissue positive for these markers is very low, however, indicative of the difficulty in acquiring a sufficient number of these cells from a patient for clinical use. Yet recently a clinical trial using proliferative human PDL cells including PDLSCs was conducted on patients with infrabony defects, revealing a significant improvement of periodontal diseases, and suggesting that cell transplantation could be a safe and promising treatment [6]. In addition, an in vitro study revealed that collagen and a synthetic polymer are useful scaffolds for PDLSC survival [7], also suggesting the feasibility of long-term analysis. However, the issue related to number of PDL cells available for regenerative treatment in clinical practice remains unresolved.

As alternative stem cells to PDLSCs, bone marrow mesenchymal stem cells (BMMSCs) have been a focus of attention to resolve the above issue because PDLSCs also express other surface markers similar to BMMSCs, such as CD9, CD10, CD13, CD29, CD44, CD49d, CD90, CD105, CD146, and CD166. Zhou and colleagues revealed the possible participation in periodontal healing of allogenic BMMSCs transplanted into irradiated mice [8]. Yang and colleagues indicated that BMMSCs were beneficial source cells, revealing the improvement of periodontal defects experimentally created in rats when transplanted directly with microcarrier gelatin beads [9].

Adipose-derived stem cells are also indicated to have probable advantages for tissue engineering applications because of their multipotency and convenient isolation in large amounts without pain for donors. The application of adipose-derived stem cells into periodontal defects in rats suggested a potential contribution to tissue healing [10]. Murine induced pluripotent stem cells that were applied with enamel matrix derivative to periodontal defects in mice implied a capability to promote periodontal regeneration [11]. These stem cells may thus have the feasibility to reconstruct the damaged periodontium, probably by communicating with surrounding dental tissue. However, the mechanism to direct these stem cells towards periodontal cells remains unclear.

In this context, researchers have focused attention on dental follicle cells (DFCs) in an effort to address this condition because DFCs are believed to be parent cells that differentiate into PDL fibroblasts as well as osteoblasts and cementoblasts fabricating cementum during development of the periodontium [12]. In the past few years, there has been energetic progress in characterizing DFCs to clarify how they were controlled during differentiation into these cells. GoPro49, a novel Golgi protein, was identified as a specific marker for DFCs [13]. Morsczeck and colleagues reported the transcriptomes and proteomes of human DFCs in relationship with osteo blastic/cementoblastic or fibroblastic differentiation [14]. Dangaria and colleagues suggested the contribution of signature gene expression, unique shifts in gene cohort expression levels, epigenetic modifications, and changes in cell morphology to the differentiation of DFCs [15]. Most recent reports have suggested the involvement of Hertwig's epithelial root sheath cells (HERSCs) in the differentiation of DFCs [16, 17]. Since HERSCs are epithelial cells that play an important role in development of tooth root, these HERSCs may also contribute to fabrication of the periodontium. Although what is central to regulating the optimum differentiation of DFCs remains uncertain, as growth of dental tissues is attributable to epithelial-mesenchymal interaction comprehensively, hereafter it may become a critical issue to elucidate participation of such epithelial cells in periodontal regeneration as well as periodontal development.

There are other trends focusing on stem cells resident in PDL tissue (that is, PDLSCs themselves) to elucidate their involvement in the regenerative process, and to develop attractive and novel regenerative treatment techniques. For these purposes several groups have attempted to establish immortalized clonal PDLSC lines for convenient and routine analyses. Our group for the first time succeeded in establishing two human clonal PDLSC lines with multipotency by transducing primary PDL cells with both SV40 large T-antigen and human telomerase reverse transcriptase genes [18–20], whereas another group presented immortalized PDLSCs by transducing bone morphogenetic protein 4 and human telomerase reverse transcriptase genes [21]. Our developed clones exhibit different characteristics from each other in multipotency, expression of stem cell makers, responsiveness to growth factors such as basic fibroblast growth factor and enamel matrix derivative, and the expression of bone morphogenetic protein 4 and fibroblast growth factor receptor 1 - suggesting that PDLSCs at diverse differentiation stages are localized in PDL tissue and that these clones were definitely derived from such PDLSCs.

We therefore believe that differential analyses between these two clones will allow us to further clarify the mechanism of PDLSC and even DFC differentiation. These results will enable elucidation of signals that direct stem cells including BMMSCs, induced pluripotent stem cells or embryonic stem cells toward PDL-lineage cells, and furthermore to identify the optimum signaling molecules and scaffolds for the periodontium regeneration, including potential signals from HERSCs. By integrating these constituents, we will be able to develop a novel regenerative medicine of the periodontium. Since complex tissue regeneration including two hard tissues and two soft tissues is required for reconstruction of the periodontium, these novel tissue engineering techniques will make it possible to develop innovative regenerative medicines with a wide field of systemic application.